跳至主要内容
临床试验/NCT02834182
NCT02834182Unknown不适用

Functional Magnetic Resonance Imaging Study: Theory of Mind Deficits in Schizophrenia and Bipolar Disorder

CHU de Reims1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
CHU de Reims
入组人数
120
试验地点
1
主要终点
Hamilton Depression Scale

研究概览

简要总结

Theory of mind (TOM), a main component of social cognition processes, refers to the capacity to infer one's own and other person's mental states. Deficits in social cognition are found in patients with schizophrenia and bipolar disorder. The purpose of this study is to compare the neurofunctional profiles of schizophrenic patients, bipolar patients and healthy participants during the performance of a TOM task. Results may help to understand the neural bases of the impairments in social cognition in schizophrenia and bipolar disorder, which may in turn help to propose potential new psychosocial therapeutic approaches in these disorders.

详细描述

Theory of mind (TOM) refer to the cognitive ability to attribute mental states to others, which plays an essential role in social communications and interactions between individuals. In several recent papers, it was shown that TOM is impaired in schizophrenia and bipolar disorder. This impairment strongly affects the quality of life in patients suffering from these disorders. The investigators study aims to explore the neural correlates of TOM in schizophrenic and bipolar patients, in comparison with those of healthy participants. These studies will be conducted on 30 schizophrenic patients, 30 bipolar patients, and 60 healthy participants, matched on age and educational level to each patient group. The investigators expect that the study of combined behavioral (neuropsychological tests) and neuro-anatomical data will allow to understand the pathophysiology of the alteration of social cognition processes in these illnesses.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Men or women aged from 18 to 65 years-old, right-handed, with a diagnosis of bipolar -disorder or schizophrenia, according to the DSM-5 criteria
  • •Native French speaker
  • •No substantial change in treatment for 2 weeks preceding study enrollment
  • •Able to provide informed written and verbal consent
  • •Healthy Controls :
  • •Men or women aged from 18 to 65 years-old, right-handed
  • •Native French speaker
  • •Able to provide informed written and verbal consent

排除标准

  • •A recent alcohol and/or drug abuse or dependence (in the last six months)
  • •A significant general medical illness, including neurological disorders or head trauma
  • •A sensorial impairment uncorrected (visual and/or hearing)
  • •Contraindication to the use of MRI
  • •Persons under legal incapacity
  • •Persons who are not covered by national health insurance
  • •Healthy Controls :
  • •Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia
  • •Depression diagnostic according to DSM-5
  • •A personal or first-degree-relative history of bipolar disorder, schizophrenia or schizoaffective disorder according to DSM-5
  • •A recent alcohol and/or drug abuse or dependence (in the last six months)
  • •A significant general medical illness, including neurological disorders or head trauma
  • •A sensorial impairment uncorrected (visual and/or hearing)
  • •Contraindication to the use of MRI
  • •People particularly protected by the law
  • •Persons who are not covered by national health insurance

研究组 & 干预措施

Bipolar Disorder patients and Schizophrenic patients

Experimental

干预措施: Hamilton Depression Scale (Behavioral)

Bipolar Disorder patients and Schizophrenic patients

Experimental

干预措施: Young Mania Rating Scale (Behavioral)

Bipolar Disorder patients and Schizophrenic patients

Experimental

干预措施: IRMf (Behavioral)

Bipolar Disorder patients and Schizophrenic patients

Experimental

干预措施: Mini International Neuropsychiatric Interview (Behavioral)

Bipolar Disorder patients and Schizophrenic patients

Experimental

干预措施: Positive And Negative Syndrom Scale (Behavioral)

Healthy Controls

Active Comparator

干预措施: IRMf (Behavioral)

Healthy Controls

Active Comparator

干预措施: Mini International Neuropsychiatric Interview (Behavioral)

Healthy Controls

Active Comparator

干预措施: Positive And Negative Syndrom Scale (Behavioral)

Healthy Controls

Active Comparator

干预措施: Young Mania Rating Scale (Behavioral)

Healthy Controls

Active Comparator

干预措施: Hamilton Depression Scale (Behavioral)

结局指标

主要结局

Hamilton Depression Scale

时间窗: Up to 15 days after inclusion

Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I.)

时间窗: Up to 15 days after inclusion

Young Mania Rating Scale

时间窗: Up to 15 days after inclusion

Scale for the Assessment for Thought, Language and Communication

时间窗: Up to 15 days after inclusion

次要结局

未报告次要终点

研究者

发起方
CHU de Reims
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验